News and Events
Inscinstech Completes Hundreds of Millions in Series C Financing to Boost Global Strategy and Innovation R&D
2025-01-18 10:56
Recently, Inscinstech announced the completion of a Series C financing round worth hundreds of millions of yuan. The round was led by the Service Trade Innovation Development Guidance Fund, with participation from Yuanhe Holdings and Inscinstech existing shareholder Luxin Venture Capital. This financing marks another significant milestone in Inscinstech rapid development journey. The funds will be allocated to the company's innovation R&D for new product pipelines, expansion of production capabilities, and will provide strong momentum for Inscinstech global strategic layout in the biopharmaceutical field.
Mr. David Li, CEO of Inscinstech, stated: "First and foremost, we sincerely thank the Service Trade Innovation Development Guidance Fund, Yuanhe Holdings, and Luxin Venture Capital for their recognition and support of Inscinstech. This not only affirms the achievements we have made but also provides strong momentum for our future rapid growth. Looking ahead, Inscinstech will uphold the core philosophy and values of 'Innovation-First,' further strengthening the R&D of our core product pipelines in the health science sector. Through our global market expansion strategy, we aim to enhance our competitiveness on the international stage. We look forward to collaborating with more domestic and international partners to jointly drive technological innovation and advancement in the industry."
Since its inception, Inscinstech has been committed to becoming a global leader in the health science sector. Leveraging strong R&D capabilities and continuous technological innovation, the company has launched a series of cutting-edge products that meet international leading standards. These include nucleic acid synthesizers, bioreactors, chromatography systems, tangential flow filtration systems, nanodrug preparation systems, high-performance liquid chromatography (HPLC) equipment, and other process devices and analytical instruments.
Inscinstech' product pipeline spans critical stages from high-throughput research, small-scale pilot, and medium-scale pilot to commercial production. The company provides end-to-end solutions and highly efficient, professional services for global clients in biopharmaceuticals, life sciences, healthcare, environmental protection, medical aesthetics, food safety, and other industries—supporting their needs from R&D to large-scale manufacturing.
Guided by customer needs, Inscinstech continuously optimizes product performance and service quality to deliver efficient and reliable solutions for industry clients. These solutions help enhance R&D and production efficiency, reduce costs, and accelerate time-to-market.
Moving forward, Inscinstech will remain driven by technological innovation, further advancing the high-quality development of the biopharmaceutical industry. The company is committed to contributing to the prosperity and progress of global healthcare.
Official Website
Social Media
